Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors
- PMID: 15162383
- DOI: 10.1002/pros.20047
Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors
Abstract
Background: The matrix metalloproteinases (MMP) are a family of proteolytic enzymes involved in facilitating cancer metastasis. Protease-activated receptors (PARs) have previously been shown to be involved in pathways of MMP upregulation by tumor cells.
Methods: Two androgen independent prostate cancer cell lines, PC3 and DU-145, and one androgen dependent prostate cancer line LNCaP, were investigated. PAR expression was detected using RT-PCR and immunofluorochemistry (IFC) techniques. MMP activity assays were used to quantify the levels of MMP-2 and -9 on all three prostate cell lines after PAR activation.
Results: RT-PCR and IFC showed the presence of PAR-1 and PAR-2 in all cell lines investigated, only LNCaP showed PAR-3 and PAR-4 expression. Increased levels of MMP-2 and MMP-9 activity, up to sevenfold depending on prostate cancer cell line, following PAR activation by specific PAR peptides was shown.
Conclusion: Preliminary studies show the activation of PAR-1 or PAR-2 produced increased levels of MMP-2 and MMP-9 activity in prostate cancer cell lines, indicating their potential role in the metastasis of prostate cancer cells.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.Prostate. 2009 May 15;69(7):774-86. doi: 10.1002/pros.20930. Prostate. 2009. PMID: 19189304
-
Expression and functional role of CCR9 in prostate cancer cell migration and invasion.Clin Cancer Res. 2004 Dec 15;10(24):8743-50. doi: 10.1158/1078-0432.CCR-04-0266. Clin Cancer Res. 2004. PMID: 15623660
-
Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer.Oncol Rep. 2004 Jun;11(6):1187-92. Oncol Rep. 2004. PMID: 15138554
-
Protease-activated receptor 1: a role in prostate cancer metastasis.Clin Prostate Cancer. 2004 Dec;3(3):189-91. doi: 10.3816/cgc.2004.n.030. Clin Prostate Cancer. 2004. PMID: 15634362 Review.
-
Human prostate cancer cell lines.Methods Mol Med. 2003;81:21-39. doi: 10.1385/1-59259-372-0:21. Methods Mol Med. 2003. PMID: 12725112 Review. No abstract available.
Cited by
-
Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors.BMC Cancer. 2008 May 28;8:149. doi: 10.1186/1471-2407-8-149. BMC Cancer. 2008. PMID: 18507821 Free PMC article.
-
Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.J Biol Chem. 2015 Oct 30;290(44):26627-37. doi: 10.1074/jbc.M115.667717. Epub 2015 Sep 9. J Biol Chem. 2015. PMID: 26354435 Free PMC article.
-
Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.Am J Physiol Gastrointest Liver Physiol. 2013 Mar 1;304(5):G479-89. doi: 10.1152/ajpgi.00186.2012. Epub 2013 Jan 10. Am J Physiol Gastrointest Liver Physiol. 2013. PMID: 23306080 Free PMC article.
-
Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review.Front Mol Biosci. 2022 Sep 29;9:896099. doi: 10.3389/fmolb.2022.896099. eCollection 2022. Front Mol Biosci. 2022. PMID: 36250005 Free PMC article. Review.
-
PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.Cancer Res. 2011 Nov 1;71(21):6561-6. doi: 10.1158/0008-5472.CAN-11-1432. Epub 2011 Oct 18. Cancer Res. 2011. PMID: 22009534 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
